About the Role

We are seeking a Remote Executive Director of Safety & Pharmacovigilance to join Kyverna Therapeutics, a pioneering biopharmaceutical company dedicated to transforming treatment for autoimmune diseases. As the Executive Director of Safety & Pharmacovigilance, you will be instrumental in shaping the global safety strategy for our innovative cell therapy pipeline. This role offers the unique opportunity to work remotely while leading a critical function within our organization.

What You'll Do

  • Define and lead the global safety and pharmacovigilance strategy across all development stages.
  • Serve as the safety subject-matter expert for cell therapy programs, addressing novel and emerging safety risks.
  • Provide strategic safety input to clinical development plans, protocols, investigator brochures, and regulatory submissions.
  • Act as a key member of cross-functional governance and program teams.
  • Oversee all pharmacovigilance activities including case processing, signal detection, risk management, and aggregate reporting.
  • Ensure compliant execution of ICSR reporting, DSURs, PBRERs/PSURs, SUSARs, and safety narratives.
  • Lead safety surveillance activities and ongoing benefit-risk assessments.
  • Review and approve safety data, medical assessments, and regulatory safety documents.

Requirements

  • MD degree with 12+ years of experience in pharmacovigilance and drug safety, including at least 5 years in a leadership role.
  • Direct experience supporting cell therapy, gene therapy, or other advanced modalities is strongly preferred.
  • Experience in clinical-stage biotech; prior BLA/MAA and/or launch experience is a plus.
  • Demonstrated success interacting with global regulatory agencies on safety matters.
  • Strong knowledge of global pharmacovigilance regulations and safety standards.
  • Excellent cross-functional leadership and communication skills.
  • Proven ability to balance compliance, scientific rigor, and business priorities.

Nice to Have

  • Experience in a lean, fast-moving biotech environment.
  • Strategic thinker with hands-on operational capabilities.
  • Prior experience in managing external vendors and CROs.

What We Offer

  • Competitive salary range of $365K-$390K annually.
  • Bonus eligibility and comprehensive benefits package.
  • Participation in the company’s stock plan.
  • Flexible remote work environment.
  • Opportunity to lead and innovate in the field of cell therapy.
Language Requirements
EnglishC1
BasicIntermediateAdvancedNative
Why This Job8.5 of 10

This role offers a unique opportunity to lead safety and pharmacovigilance in a cutting-edge biotech company. With a competitive salary and remote work flexibility, it's an attractive position for experienced professionals.

Salary Range
Required
0/1
Optional
0/1
Bonus
0/1

Who Will Succeed Here

Deep expertise in pharmacovigilance processes and regulations, particularly in cell therapy, ensuring compliance with FDA and EMA guidelines.

Proven ability to lead cross-functional teams in a remote environment, utilizing tools like Slack and Asana to coordinate efforts between clinical, regulatory, and safety departments.

Strong analytical mindset with experience in risk management frameworks and clinical development strategies, capable of making data-driven decisions to enhance patient safety.

Learning Resources

Pharmacovigilance: A Practical Guideguide

Career Path

Remote Executive Director of Safety & Pharmacovigilance(Now)Vice President of Pharmacovigilance and Safety(2-4 years)Chief Safety Officer or Chief Medical Officer(4-6 years)

Market Overview

Market Size 2024
$9.5B
Annual Growth
10.2%
AI Adoption in Pharmacovigilance
47%
Investment in Safety Tech
+30%
Labour Demand for Pharmacovigilance Professionals
+25%
Avg Salary for Executive Director of Safety & Pharmacovigilance
$180K

Skills & Requirements

Required
PharmacovigilanceCell TherapyRegulatory Compliance
Growing in Demand
Data AnalyticsArtificial Intelligence in HealthcareRegulatory Writing
Declining
Traditional Reporting SystemsPaper-based Documentation

Domain Trends

Increased Use of AI in Drug Safety
AI technologies are being increasingly adopted in pharmacovigilance, with 47% of organizations reporting AI integration for data analysis and adverse event reporting.
Shift Towards Real-World Evidence
The use of real-world evidence in pharmacovigilance is expected to grow by 40% by 2025, as companies seek to enhance safety profiles of therapies based on actual patient data.
Regulatory Changes and Compliance
With new regulations emerging, 60% of pharmacovigilance professionals are focusing on enhanced regulatory compliance strategies to meet evolving standards.

Industry News

Loading latest industry news...

Finding relevant articles from the last 6 months

All job postings are automatically gathered by algorithms. We do not review or verify listings, be careful when applying and do not sign-in with iCloud or Google services.